#229 Pharmacogenomics with Avni Santani
39:51 Share

*We have an exciting announcement, we are launching a Patreon! For those that are not familiar with Patreon, it’s a platform that allows creators (like podcasters) to offer their followers more content, experiences, and even gifts. In order to provide what YOU want, please take *60 seconds to fill out our survey)*. By filling out the survey) not only are you influencing what benefits we will offer, but you will be the first to know when we will launch! Can’t thank you all enough for your listenership over the years, it’s such a privilege to be able to launch a Patreon to engage with you all more. *

This week we’re chatting about an emerging area of genetics, pharmacogenomics! Pharmacogenomics) (PGx), one of the core elements of personalized medicine, is a field of research that studies how a person’s genes affect how they respond to medications. Its long-term goal is to help doctors select the drugs and doses best suited for each person.

Joining us for this conversation is Avni Santani) PhD, FACMG, Chief Medical Officer of Veritas Genetics), a LetsGetChecked company), which delivers tailored at-home healthcare solutions to 300+ organizations. Dr. Santani holds a Master’s degree in Medical Molecular Genetics from the University of Aberdeen and a PhD in Genetics from Texas A&M University. She holds specialty board certifications in Clinical Molecular Genetics and Clinical Cytogenetics from The Children’s Hospital of Philadelphia (CHOP).

On This Episode We Discuss:

Pharmacogenomics and other similar terms

The state of genetic testing today and how it has changed in the last ten years

Why it is helpful to have pharmacogenomic testing information when figuring out the best drugs to prescribe

Steps of drug metabolism that gene variants can affect

How gene variants can impact the drug response (drug reception, uptake, and breakdown)

If testing can provide information on the dosage of drugs to prescribe and how this varies between people

Types of conditions/diseases where genetic testing results can be applied (behavioral health, cardiovascular health, and pain management)

The role of testing in determining personal risk levels of becoming addicted to pain medications

Genes that LetsGetChecked’s myPGx test) analyzes

The frequency at which gene variants found through this testing help narrow down which drug or dose to prescribe

If you want to learn more about pharmacogenomics, head over to the LetsGetChecked website).

Be sure to follow our guest, Avni Santani, on Twitter); LetsGetChecked on Twitter), Facebook), LinkedIn), Instagram), YouTube); and VeritasGenetics on Twitter), Facebook), and Instagram).

Stay tuned for the next new episode of DNA Today on March 31st, 2023, where we’ll be diving deeper into pharmacogenomics (PGx) with James Fettig who will provide an overview of PGx for cancer! New episodes are released every Fridays. In the meantime, you can binge over 225 other episodes on Apple Podcasts), Spotify), streaming on the website), or any other podcast player by searching, “DNA Today”. Episodes since 2021 are also recorded with video which you can watch on our YouTube channel).

DNA Today is hosted and produced by Kira Dineen. Our social media lead is Corinne Merlino. Our video lead is Amanda Andreoli. Our outreach Intern is Sanya Tinaikar. Our Social Media Intern is Kajal Patel. And our Graphic Designer Ashlyn Enokian.

See what else we are up to on Twitter), Instagram), Facebook), YouTube) and our website, DNAToday.com). Questions/inquiries can be sent to [email protected]).

Surely you have heard of whole genome sequencing, but what about rapid and ultra-rapid whole genome sequencing? This is an emerging method of diagnosing genetic conditions for quick management. PerkinElmer Genomics offers this incredibly valuable test, which can be life saving for ill babies and kids. Learn more in our full episode (**#226)) with PerkinElmer Genomics. You can visit perkinelmergenomics.com) for more information. (Sponsored)

As a listener of DNA Today, you probably heard me talk about NIPT, non-invasive prenatal screening, that looks for extra or missing chromosome conditions during pregnancy. But did you know there is one that can also screen for recessive disorders (like cystic fibrosis) and fetal antigens? BillionToOne offers UNITY Screen, which does all this from one blood draw from a pregnant person. Visit unityscreen.com) for more info. Listen to DNA Today Episode* #224 Single Gene NIPT*)* and** #225 Fetal Antigen NIPT*). (Sponsored)

Juno Diagnostics has developed the next generation of non-invasive prenatal tests so that all pregnant people can access a higher standard of care. Juno Diagnostics is the only genetic testing company on the market that performs NIPS for common aneuploidies* *on blood samples from a finger stick instead of a traditional venous blood draw. That means you collect your sample on your own time, at home, and still have NIPS at a CLIA laboratory! Juno’s Hazel™ NIPS screens for common chromosome variations seen in pregnancy, such as Down syndrome or trisomy 21, trisomy 13, and trisomy 18 – in addition to testing for fetal sex. You can order this test yourself, or have your healthcare provider order for you. Head to JunoDx.com and use the code "DNATODAY” for 10% off! Keep your eye out for our full episode interview with experts from Juno Dx including fellow genetic counselor Katie Sagaser and Dr. Allison Rodgers. In the meantime, check out JunoDx.com to learn more about Hazel and their other test Birch (which tests just for the sex of your baby). (Sponsored)